Literature DB >> 3579218

Amino acids, glutathione, and glutathione transferase activity in the brains of patients with Alzheimer's disease.

T L Perry, V W Yong, C Bergeron, S Hansen, K Jones.   

Abstract

We measured the contents of amino acids and related amino compounds in autopsied brain from 22 patients with Alzheimer's disease (AD) and in cortical biopsy specimens from 2 other patients. The diagnosis of AD was established neuropathologically in all 24 patients by the presence of both neurofibrillary tangles and neuritic plaques in neocortex. The mean contents of gamma-aminobutyric acid (GABA), and of the GABA dipeptide homocarnosine, were significantly reduced in frontal and occipital cortices and in hippocampus of the autopsied brains of AD patients compared to control patients without neurological disease. However, GABA contents were normal in frontal cortex in biopsy samples from 2 patients. Phosphoethanolamine contents were significantly reduced at autopsy in frontal and occipital cortex, and in the substantia innominata. We found no evidence of a deficiency of glutamate, aspartate, or taurine in AD brain, as has been claimed. Glutathione contents and glutathione transferase activities were normal in frontal cortex and substantia innominata. The mechanism of neuronal death in patients with AD is unlikely to involve either insufficient synthesis of glutathione or failure to conjugate free radicals with glutathione.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3579218     DOI: 10.1002/ana.410210403

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  23 in total

1.  NADPH-diaphorase-positive cell populations in the human amygdala and temporal cortex: neuroanatomy, peptidergic characteristics and aspects of aging and Alzheimer's disease.

Authors:  J W Unger; W Lange
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

Review 2.  Redox Signaling Mediated by Thioredoxin and Glutathione Systems in the Central Nervous System.

Authors:  Xiaoyuan Ren; Lili Zou; Xu Zhang; Vasco Branco; Jun Wang; Cristina Carvalho; Arne Holmgren; Jun Lu
Journal:  Antioxid Redox Signal       Date:  2017-05-18       Impact factor: 8.401

3.  Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.

Authors:  C D Smith; J M Carney; P E Starke-Reed; C N Oliver; E R Stadtman; R A Floyd; W R Markesbery
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

4.  Correcting miR92a-vGAT-Mediated GABAergic Dysfunctions Rescues Human Tau-Induced Anxiety in Mice.

Authors:  Xiaoguang Li; Zhihao Wang; Lu Tan; Yali Wang; Chengbiao Lu; Rongxiang Chen; Shujuan Zhang; Yuan Gao; Yanchao Liu; Yaling Yin; Xinghua Liu; Enjie Liu; Ying Yang; Yu Hu; Zhipeng Xu; Fuqiang Xu; Jie Wang; Gong-Ping Liu; Jian-Zhi Wang
Journal:  Mol Ther       Date:  2017-01-04       Impact factor: 11.454

Review 5.  Role of Glutamate and NMDA Receptors in Alzheimer's Disease.

Authors:  Rui Wang; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

6.  Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease.

Authors:  M A Smith; R K Kutty; P L Richey; S D Yan; D Stern; G J Chader; B Wiggert; R B Petersen; G Perry
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

7.  Evidence of an oxidative challenge in the Alzheimer's brain.

Authors:  L Balazs; M Leon
Journal:  Neurochem Res       Date:  1994-09       Impact factor: 3.996

8.  X-ray absorption spectroscopy at the sulfur K-edge: a new tool to investigate the biochemical mechanisms of neurodegeneration.

Authors:  Mark J Hackett; Shari E Smith; Phyllis G Paterson; Helen Nichol; Ingrid J Pickering; Graham N George
Journal:  ACS Chem Neurosci       Date:  2012-01-02       Impact factor: 4.418

9.  Evidence for a membrane defect in Alzheimer disease brain.

Authors:  R M Nitsch; J K Blusztajn; A G Pittas; B E Slack; J H Growdon; R J Wurtman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

10.  Detection of glutamine synthetase in the cerebrospinal fluid of Alzheimer diseased patients: a potential diagnostic biochemical marker.

Authors:  D Gunnersen; B Haley
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.